| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | SMLR Semler Scientific, Inc. | Murphy-Chutorian Douglas84 | CEO, Interim CFO And Director | Sell | 70,406 | $20.21 | $1,422,608.22 | -36.6% | - | - | |
| Nov 17, 2025 | INCY Incyte Corp | Denton Sheila A. | EVP &General Counsel | Sell | 278 | $104.36 | $29,012.08 | -1.0% | -2.9% | - | |
| Nov 17, 2025 | OM Outset Medical, Inc. | Nash Marc83 | EVP Operations R&D &Service | Sell | 247 | $4.60 | $1,136.20 | -0.5% | -33.9% | - | |
| Nov 17, 2025 | TELA Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P.57 | - | Buy | 3,604,000 | $1.11 | $4,000,440.00 | +87.7% | -32.8% | - | |
| Nov 17, 2025 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 12,787 | $45.09 | $576,501.98 | -3.8% | -19.1% | - | |
| Nov 17, 2025 | STXS Stereotaxis, Inc. | Isaac Paul J78 | Director, See Remarks | Buy | 30,000 | $2.22 | $66,600.00 | +1.1% | -1.9% | - | |
| Nov 17, 2025 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 12,787 | $44.92 | $574,392.29 | -3.1% | -19.1% | - | |
| Nov 17, 2025 | IRIX Iridex Corp | Moore William M80 | Director | Buy | 50,000 | $0.97 | $48,331.95 | +11.6% | +40.6% | - | |
| Nov 17, 2025 | LAB Standard Biotools Inc. | Casdin Partners Master Fund, L.P.53 | Director, 10% Owner | Buy | 925,000 | $1.22 | $1,126,775.00 | +0.5% | -7.4% | - | |
| Nov 14, 2025 | TNON Tenon Medical, Inc. | Grawey Nathaniel A. | Chief Commercial Officer | Buy | 101,167 | $0.00 | - | +73.2% | -39.7% | - | |
| Nov 14, 2025 | TNON Tenon Medical, Inc. | Geist Wyatt D. | Chief Innovation Officer | Buy | 19,455 | $0.00 | - | +14.1% | -39.7% | - | |
| Nov 14, 2025 | RVP Retractable Technologies Inc | Shaw Thomas J50 | President And CEO | Buy | 5,731 | $0.77 | $4,424.33 | - | -14.3% | - | |
| Nov 14, 2025 | IRIX Iridex Corp | Dizon Romeo R64 | Chief Financial Officer | Buy | 14,769 | $0.88 | $12,996.72 | +23.8% | +40.8% | - | |
| Nov 14, 2025 | TNON Tenon Medical, Inc. | Foster Steven M | CEO And President | Buy | 19,455 | $0.00 | - | +568.4% | -39.7% | - | |
| Nov 14, 2025 | SYK Stryker Corp | Berry William E Jr | VP, Chief Accounting Officer | Sell | 1,953 | $365.49 | $713,801.97 | -40.8% | +1.0% | - | |
| Nov 14, 2025 | DXCM Dexcom Inc | Collins Richard Alexander59 | Director | Sell | 2,906 | $59.05 | $171,599.30 | -7.6% | +12.1% | - | |
| Nov 13, 2025 | AORT Artivion, Inc. | Stanton Marshall S.51 | SVP, Clinical &MD Affair | Sell | 4,993 | $45.86 | $228,968.99 | -8.1% | -12.0% | - | |
| Nov 13, 2025 | RGEN Repligen Corp | Hunt Anthony75 | Director | Sell | 20,000 | $154.61 | $3,092,278.36 | -3.1% | -7.4% | - | |
| Nov 13, 2025 | CATX Perspective Therapeutics, Inc. | Hunt Jonathan Robert61 | Chief Accounting Officer | Buy | 11,000 | $2.03 | $22,294.80 | +22.5% | +135.7% | - | |
| Nov 13, 2025 | AORT Artivion, Inc. | Holloway Jean F49 | SVP, General Counsel | Sell | 5,761 | $45.86 | $264,187.94 | -3.4% | -12.0% | - | |
| Nov 13, 2025 | ELUT Elutia Inc. | Mills C Randal65 | President And CEO | Buy | 13,500 | $0.75 | $10,110.00 | +1.3% | +21.2% | - | |
| Nov 13, 2025 | AORT Artivion, Inc. | Davis John E | Chief Commercial Officer | Sell | 6,563 | $45.86 | $300,966.05 | -3.2% | -12.0% | - | |
| Nov 13, 2025 | ZOMDF Zomedica Corp. | Klass Russell Kevin | Sr Vice President, Sales | Buy | 150,000 | $0.10 | $14,550.00 | +2.7% | - | - | |
| Nov 13, 2025 | AORT Artivion, Inc. | Horton Amy48 | VP, Chief Accounting Officer | Sell | 3,482 | $45.86 | $159,677.56 | -2.4% | -12.0% | - | |
| Nov 13, 2025 | SRTS Sensus Healthcare, Inc. | Sachetta Eric | Director | Buy | 2,500 | $4.50 | $11,250.00 | +1.9% | +6.7% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.